Determinants of resistance to 2′, 2′-difluorodeoxycytidine (gemcitabine)

AM Bergman, HM Pinedo, GJ Peters - Drug Resistance Updates, 2002 - Elsevier
The inherent or induced resistance of tumors to cytostatic agents is a major clinical problem.
In this review, we summarize the pre-clinical mechanisms of acquired and inherent …

The mechanism of action of radiosensitization of conventional chemotherapeutic agents

TS Lawrence, AW Blackstock, C McGinn - Seminars in radiation oncology, 2003 - Elsevier
It is not an exaggeration to state that most of the advances in curing cancer in the last
decade have come from successful combinations of conventional chemotherapeutic agents …

Combined modality therapy of gemcitabine and radiation

B Pauwels, AEC Korst, F Lardon… - The oncologist, 2005 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to: List the
advantages of combination chemotherapy and radiotherapy. Explain the rationale for doing …

Interaction of p53 and DNA-PK in response to nucleoside analogues: potential role as a sensor complex for DNA damage

G Achanta, H Pelicano, L Feng, W Plunkett, P Huang - Cancer research, 2001 - AACR
Therapeutic nucleoside analogues such as ara-C, gemcitabine, and fludarabine exert their
cytotoxic activity against cancer cells mainly by incorporation into DNA and disruption of …

[HTML][HTML] Combined aberrant expression of NDRG2 and LDHA predicts hepatocellular carcinoma prognosis and mediates the anti-tumor effect of gemcitabine

Y Guo, X Sun, J Wang, X Yang, X Zhou… - … journal of biological …, 2019 - ncbi.nlm.nih.gov
The Warburg effect is one of the important hallmarks of cancer. The activation of oncogene
and inactivation of tumor suppressor gene contribute to the enhancement of glycolytic …

Role of checkpoint kinase 1 in preventing premature mitosis in response to gemcitabine

MA Morgan, LA Parsels, JD Parsels, AK Mesiwala… - Cancer research, 2005 - AACR
Abstract The deoxycytidine analogue 2′, 2′-difluoro-2′-deoxycytidine (gemcitabine) is a
potent radiation sensitizer in a variety of solid tumors and tumor cell lines. Previous studies …

Expression of a non‐functional p53 affects the sensitivity of cancer cells to gemcitabine

CM Galmarini, ML Clarke, N Falette… - … journal of cancer, 2002 - Wiley Online Library
Gemcitabine is a relatively new agent with promising activity in solid tumors. Few data are
available regarding mechanisms of resistance to gemcitabine downstream from the drug …

Antimetabolites: established cancer therapy.

M Tiwari - Journal of Cancer Research & Therapeutics, 2012 - search.ebscohost.com
Cell death has been divided into two main types: programmed cell death, in which the cell
plays an active role, and passive (necrotic) cell death. Senescence arrest, accelerated …

Molecular targets of gemcitabine action: rationale for development of novel drugs and drug combinations

M Elnaggar, E Giovannetti… - Current pharmaceutical …, 2012 - ingentaconnect.com
Gemcitabine is one of the most widely used pyrimidine analogues, with a well-established
role as a first-and second-line treatment of several types of tumors. Several preclinical and …

Cell cycle effect of gemcitabine and its role in the radiosensitizing mechanism in vitro

B Pauwels, AEC Korst, GGO Pattyn… - International Journal of …, 2003 - Elsevier
PURPOSE: The mechanism of radiosensitization by gemcitabine is still unclear. It has been
hypothesized that the accumulation of cells in early S phase may play a role in enhancing …